Dr Rodrigo Ruiz is Head of Country Pharmacovigilance for Mexico in Bristol - Myers Squibb Mexico products, monitoring a portfolio including innovator and biotechnologist. Dr Rodrigo Ruiz has extensive experience in major Pharmacovigilance and Medicines Benefit - Risk Management.
Rodrigo is a registered physician from the La Salle University - Mexican Faculty of Medicine and specialised in Pharmaceutical Medicine. On 2014 he was graduated from a Global Master in Business Administration (MBA) from Arizona State University (ASU) - School of Global Management. He joined the pharmaceutical industry in 2008, as a Pharmacovigilance Associate II.